Current development of therapeutic vaccines for the treatment of chronic infectious diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Pil-Gu | - |
dc.contributor.author | Fatima, Munazza | - |
dc.contributor.author | An, Timothy | - |
dc.contributor.author | Moon, Ye-Eun | - |
dc.contributor.author | Woo, Seungkyun | - |
dc.contributor.author | Youn, Hyewon | - |
dc.contributor.author | Hong, Kee-Jong | - |
dc.date.accessioned | 2024-03-02T02:30:36Z | - |
dc.date.available | 2024-03-02T02:30:36Z | - |
dc.date.issued | 2024-01 | - |
dc.identifier.issn | 2287-3651 | - |
dc.identifier.issn | 2287-366X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90511 | - |
dc.description.abstract | Chronic infectious diseases refer to diseases that require a long period of time from onset to cure or death, the use of therapeutic vaccines has recently emerged to eradicate diseases. Currently, clinical research is underway to develop therapeutic vaccines for chronic infectious diseases based on various vaccine formulations, and the recent success of the messenger RNA vaccine platform and efforts to apply it to therapeutic vaccines are having a positive impact on conquering chronic infectious diseases. However, since research on the development of therapeutic vaccines is still relatively lacking compared to prophylactic vaccines, there is a need to focus more on the development of therapeutic vaccines to overcome threats to human health caused by chronic infectious diseases. In order to accelerate the development of therapeutic vaccines for chronic infectious diseases in the future, it is necessary to establish a clear concept of therapeutic vaccines suitable for the characteristics of each chronic infectious disease, as well as standardize vaccine effectiveness evaluation methods, secure stan-dards/reference materials, and simplify the vaccine approval procedure. © Korean Vaccine Society. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Vaccine Society | - |
dc.title | Current development of therapeutic vaccines for the treatment of chronic infectious diseases | - |
dc.type | Article | - |
dc.identifier.doi | 10.7774/cevr.2024.13.1.21 | - |
dc.identifier.bibliographicCitation | Clinical and Experimental Vaccine Research, v.13, no.1, pp 21 - 27 | - |
dc.identifier.kciid | ART003049906 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85185664347 | - |
dc.citation.endPage | 27 | - |
dc.citation.startPage | 21 | - |
dc.citation.title | Clinical and Experimental Vaccine Research | - |
dc.citation.volume | 13 | - |
dc.citation.number | 1 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Chronic infectious disease | - |
dc.subject.keywordAuthor | Clinical trials | - |
dc.subject.keywordAuthor | Therapeutic vaccine | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.